In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2. (Q54388604)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

title

In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

author name string

McMannis JD

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

Fisher RI

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

Creekmore SP

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

Braun DP

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

Harris JE

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

Ellis TM

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

language of work or name

English

0 references

publication date

1 February 1988

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

published in

Journal of Immunology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

volume

140

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

page(s)

1335-1340

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

Identifiers

PubMed publication ID

3257776

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3257776

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/3257776

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54388604&oldid=931800876"